Om

EDX Medical Group Plc is a healthcare company that develops and delivers innovative digital diagnostic products and services. It focuses on cancer, heart disease, neurology, and infectious disease testing, with additional solutions for diabetes, obesity, inflammatory disorders, kidney, and liver conditions. The company helps predict disease risk, inform clinical decision-making, and accelerate new medicine development by translating clinical insights into pragmatic solutions that combine advanced biological and digital technologies. This approach aims to improve early disease detection and personalize disease management cost-effectively. EDX Medical Group Plc operates a molecular biology and diagnostics laboratory in Cambridge, UK, where it conducts research and development, provides testing and genomic sequencing services, performs quality assurance, and designs, develops, validates, and sources diagnostic tests at commercial scale. Key tests in this facility have received accreditation to ISO 15189 from the United Kingdom Accreditation Service. Incorporated in 2021 and headquartered in Cambridge, United Kingdom, EDX Medical Group Plc plays a role in advancing precision diagnostics within the healthcare sector.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I EDX MEDICAL GROUP MED ENDAVU: Køb EDX Medical Group ($EDX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i EDX Medical Group, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.